Altamira Therapeutics Reaches Midpoint for Enrollment in Clinical Trial with Bentrio in Seasonal Allergic Rhinitis in Australia
Swift progress of study enrollment - midpoint of 50 patients reachedInterim analysis confirmed target enrollment of 100 patientsCompletion of enrollment expected by early January 2023HAMILTON, BERMUDA